Breast Cancer Clinical Trial

Clinical Trial Finder Breast Cancer Trials

The Impact of Tamoxifen and Aromatase Inhibitors on Platelet Proteins

See Locations Near You

Summary

Single phlebotomy study involving women receiving tamoxifen or aromatase inhibitor therapy.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

women routinely taking tamoxifen or aromatase inhibitor therapy as prescribed by their oncologist

Exclusion Criteria:

Use of heparin, warfarin

Study is for people with:

Breast Cancer

Estimated Enrollment:

30

Study ID:

NCT01341171

Recruitment Status:

Completed

Sponsor:

University of Vermont

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

University of Vermont
Burlington Vermont, 05401, United States

How clear is this clinincal trial information?

Study is for people with:

Breast Cancer

Estimated Enrollment:

30

Study ID:

NCT01341171

Recruitment Status:

Completed

Sponsor:


University of Vermont

How clear is this clinincal trial information?

Clinical Trial Resources

SurvivorNet’s Guide To Clinical Trials: What Are They And Are They Right for You?
Clinical Trials for Breast Cancer
Have You Been Diagnosed With Late-Stage Breast Cancer? Know That You Have Treatment Options.
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider